[1] WOLF H,WANDT H,JONAT W.I mmunohistochemical evidence of estrogen and progesterone receptors in the female lower urinary tract and comparison with the vagina[J].Gynecol Obstetric Invest,1991,32(4):227-231.
[2] BATRA S C,IOSIF C S.Progesterone receptors in the female lower urinary tract[J].J Urol,1987,138(5):1301-1304.
[3] van VOORHIS B J.Genitourinary symptoms in the menopausal transition[J].Am J Med,2005,118(12B):47-53.
[4] TELEMAN P M,PERSSON J,MATTIASSON A,et al.The relation between urinary incontinence and steroid hormone levels in perimenopausal women.A report from the Women's Health in the Lund Area (WHILA) study[J].Acta Obstet Gynecol Scand,2009,88(8):927-932.
[5] GOPAL M,SAMME M D L,ARYA L A,et al.Association of change in estradiol to lower urinary tract symptoms during the menopausal transition[J].Obstet Gynecol,2008,112(5):1045-1052.
[6] COPP H L,WONG I Y,KRISHNAN C,et al.Clinical presentation and urachal remnant pathology:implications for treatment[J].J Urol,2009,182(4):1921-1924.
[7] 陶乐,邱建新.泌尿系统肿瘤中雌激素受体作用的研究进展[J].世界临床药物,2014(6):338-342.
[8] IMAMOV O,YAKIMCHUK K,MORANI A,et al.Estrogen receptor β-deficient female mice develop a bladder phenotype resembling human interstitial cystitis[J].Proc Natl Acad Sci U S A,2007,104(23):9806-9809.
[9] SELLERS D J,MCKAY N.Developments in the pharmacotherapy of the overactive bladder[J].Curr Opin Urol,2007,17(4):223-230.
[10] MILSOM I,ABRAMS P,CARDOZO L,et al.How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study[J].BJU Int,2001,87(9):760-766.
[11] ANDERSSON K E.The overactive bladder:pharmacologic basis of drug treatment[J].Urology,1997,50(6A):74-84.
[12] HASHIM H,ABRAMS P.Is the bladder a reliable witness for predicting detrusor overactivity?[J].J Urol,2006,175(1):191-194.
[13] BRADING A F,TURNER W H.The unstable bladder:towards a co mmon mechanism[J].Br J Urol,1994,73(1):3-8.
[14] BRADING A F.a myogenic bais for the overactive bladder[J].Urology,1997,50(6A):57-67.
[15] HONG S K,YANG J H,KIM T B,et al.Effects of ovariectomy and oestrogen replacement on the function and expression of Rho-kinase in rat bladder smooth muscle[J].BJU Int,2006,98(5):1114-1117.
[16] YOSHIDA J,AIKAWA K,YOSHIMURA Y,et al.The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch-induced acetylcholine release in female rat bladder[J].Neurourol Urodyn,2007,26(7):1050-1055.
[17] FERGUSON D R,KENNEDY I,BURTON T J.ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes——a possible sensory mechanism?[J].J Physiol,1997,505(Pt2):503-511.
[18] MAGGI C A.Prostanoids as local modulators of reflex micturition[J].Pharmacol Res,1992,25(1):13-20.
[19] BIRDER L A,APODACA G,de GROAT W C,et al.Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder[J].Am J Physiol,1998,275(2Pt2):F226-229.
[20] ANDERSSON K E.Bladder activation:afferent mechanisms[J].Urology,2002,59(5 Suppl 1):43-50.
[21] SILVA C,RIBEIRO M J,CRUZ F.The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input[J].J Urol,2002,168(2):575-579.
[22] ARCHER D F.Efficacy and tolerability of local estrogen therapy for urogenital atrophy[J].Menopause,2010,17(1):194-203.
[23] GRIEBLING T L,LIAO Z,SMITH P G.Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women[J].Menopause,2012,19(6):630-635.
[24] TANⅡR Y,ERCAN F,TARCAN T.Exogenous testosterone and estrogen affect bladder tissue contractility and histomorphology differently in rat ovariectomy model[J].J Sex Med,2011,8(6):1626-1637.
[25] YU Y,SHEN Z,ZHOU X,et al.Effects of steroid hormones on morphology and vascular endothelial growth factor expression in female bladder[J].Urology,2009,73(6):1210-1217.
[26] ROBINSON D,CARDOZO L D.The role of estrogens in female lower urinary tract dysfunction[J].Urology,2003,62(4 Suppl 1):45-51.
[27] RUFFORD J,HEXTALL A,CARDOZO L,et al.A double-blind placebo-controlled trial on the effects of 25mg estradiol implants on the urge syndrome in postmenopausal women[J].Int Urogynecol J Pelvic Floor Dysfunct,2003,14(2):78-83.
[28] ROBINSON D,CARDOZO L.Oestrogens and the lower urinary tract[J].BJOG,2004,111(Suppl 1):10-14.
[29] ERIKSEN P S,RASMUSSEN H.Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis:a double-blind placebo controlled study[J].Eur J Obstet Gynecol Reprod Biol,1992,44(2):137-144.
[30] ŠIMUNIC V,BANOVIC I,CIGLAR S,et al.Local estrogen treatment in patients with urogenital symptoms[J].Int J Gynaecol Obstet,2003,82(2):187-197.
[31] CARDOZO L,LOSE G,MCCLISH D,et al.A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder[J].Acta Obstet Gynecol Scand,2004,83(10):892-897. |
